What is Re-gen Active Lab?
Re-gen Active Lab operates as a specialized, FDA-registered tissue establishment focused on the production of human umbilical cord and amniotic membrane-derived biomolecules. The company distinguishes itself through a rigorous commitment to safety and regulatory compliance, utilizing AABB-accredited cord banks to source raw materials. Their product portfolio, which includes exosomes, proteins, and growth factors, serves as a critical supply chain component for advanced regenerative therapies. By maintaining strict environmental controls and donor screening protocols, the organization ensures the consistency and quality required for clinical-grade applications in the biotechnology industry.
How much funding has Re-gen Active Lab raised?
Re-gen Active Lab has raised a total of $2.3M across 2 funding rounds:
Debt
$24K
Other Financing Round
$2.3M
Debt (2021): $24K with participation from PPP
Other Financing Round (2024): $2.3M, investors not publicly disclosed
Key Investors in Re-gen Active Lab
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed institutional partner participating in the most recent strategic financing round.
Undisclosed Investor
An undisclosed investor providing capital to support the company's enterprise-level growth objectives.
What's next for Re-gen Active Lab?
With the recent influx of capital, Re-gen Active Lab is expected to transition from its current operational phase into a period of aggressive market expansion and infrastructure development. The strategic allocation of these funds will likely prioritize the scaling of manufacturing facilities to meet the rising demand for naturally occurring biomolecules. Furthermore, the company is well-positioned to deepen its research and development initiatives, potentially exploring new therapeutic applications for its proprietary growth factors. As the regenerative medicine market continues to mature, Re-gen Active Lab's focus on quality assurance and regulatory excellence will be instrumental in maintaining its competitive advantage and securing long-term industry partnerships.
See full Re-gen Active Lab company page
